Status: current, Primitive. Date: 31-Jan 2004. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2150927017 | Bortezomib (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
2158720013 | Bortezomib | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bortezomib | Is a | Antineoplastic agent | false | Inferred relationship | Some | ||
Bortezomib | Is a | Proteasome inhibitor | true | Inferred relationship | Some | ||
Bortezomib | Has disposition | Proteasome inhibitor | true | Inferred relationship | Some | ||
Bortezomib | Is a | Immunologic agent | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Bortezomib only product | Has active ingredient | True | Bortezomib | Inferred relationship | Some | 1 |
Bortezomib-containing product in parenteral dose form | Has active ingredient | True | Bortezomib | Inferred relationship | Some | 1 |
Bortezomib only product in parenteral dose form | Has active ingredient | True | Bortezomib | Inferred relationship | Some | 1 |
Bortezomib 3.5 mg powder for solution for injection vial | Has BoSS | True | Bortezomib | Inferred relationship | Some | 1 |
Bortezomib 3.5 mg powder for solution for injection vial | Has precise active ingredient | True | Bortezomib | Inferred relationship | Some | 1 |
Bortezomib 3.5mg lyophilized powder for injection | Has active ingredient | False | Bortezomib | Inferred relationship | Some | |
Velcade 3.5mg lyophilised powder for injection | Has active ingredient | False | Bortezomib | Inferred relationship | Some | |
Bortezomib-containing product | Has active ingredient | True | Bortezomib | Inferred relationship | Some | 1 |
Reference Sets
Adverse reaction agent reference set
Substance foundation reference set